Searched for
SUVEN PHARMACEUTICALS SHARES
Ahead of Market: 10 things that will decide stock market action on TuesdayIndian indices were subdued with Nifty up 0.03% and Sensex down 0.10%. High volatility (VIX at 19.63) and bearish momentum indicators sugge...- I-Sec initiates coverage on Suven Pharmaceuticals with a Buy rating, target price Rs 1,400ICICI Securities recommends buying Suven Pharmaceuticals with a target price of Rs 1,400. The firm exhibits strong quarterly growth, report...
- Suven, Cohance aim to double combined business revenue to Rs 6,000 cr by FY29Suven Pharmaceuticals and Cohance Lifesciences plan to merge and aim to double their revenue to Rs 6,000 crore by FY29 through organic and ...
- National Company Law Tribunal clears Casper Pharma’s merger with Suven PharmaceuticalsThe NCLT Mumbai has approved the merger of Casper Pharma with Suven Pharmaceuticals. This merger aims to improve efficiency, reduce costs, ...
- Merger effect! Suven Pharma shares jump 15% in 2 daysAfter the merger becomes effective, all shareholders of Cohance will be issued shares of Suven at the ratio of 11 shares of Suven for every...
- Suven Pharmaceuticals shares soar 13% on proposed merger with Cohance LifesciencesShares of Suven Pharmaceuticals surged 13% on the NSE after proposing a merger with Cohance Lifesciences to strengthen its CDMO industry po...
- Suven Pharma, Cohance Lifesciences to merge to bolster CDMO businessPromoter of Suven Pharma, Advent International, had said last year that it would merge the two businesses post the buyout of its significan...
- Suven Pharmaceuticals shares jump over 6% after cabinet approves Rs 9,589 crore FDIAccording to the latest shareholding pattern available with the exchanges, as of 30 June 2023, 60% of the company's shareholding is with th...
- Cabinet approves foreign investment of up to Rs 9,589 crore in Suven PharmaThe Cabinet Committee on Economic Affairs has approved foreign investment of up to Rs 9,589 crore in Suven Pharmaceuticals by Cyprus-based ...
- Buy Suven Pharmaceuticals, target price Rs 520: Nuvama Wealth brokerageBroken 3-month consolidation range on the higher side affirming a strong base formation at 470 levels.
- CCI clears Berhyanda's acquisition of Suven PharmaThe acquisition is “by way of a share purchase agreement of December 26, 2022 and pursuant to the mandatory open offer in compliance with t...
- Advent pips Blackstone, set to buy Suven Pharma for Rs 6300 crMarket capitalisation of Suven Pharma, as on Friday, was ₹12,682.43 crore. ET was the first to report on the sale on December 23. Advent is...
- Advent pips Blackstone, set to buy Suven Pharma for Rs 6300 crAnnouncement expected as early as Monday morning. Open offer if fully subscribed to could make it a $1 bn deal
- Accumulate Suven Pharmaceuticals, target price Rs 602: Geojit Financial ServicesSuven Pharma’s total revenues grew 40% YoY to Rs.364 crore with the Formulations and CRAMS (pharma) reporting stellar growth this quarter o...
- Buy Suven Pharmaceuticals, target price Rs 627: Anand RathiSuven Pharmaceuticals Ltd., incorporated in the year 2018, is a Small Cap company (having a market cap of Rs 13147.01 Crore) operating in P...
- Suven Pharma Q1 results: Net profit down 0.41% at Rs 92 croreConsolidated revenue of the company stood at Rs 243.97 crore for the quarter under consideration. It was at Rs 199.83 crore in the same per...
- Suven plans to buy US-based Rising Pharmaceuticals' assetsShore Suven Pharma Inc is a joint venture between Suven Life Sciences and Shore Pharma Investments LLC of USA.
- Suven inks licensing pact with Taro Pharma for scalp lotionSuven Life Sciences said it has given exclusive license to Taro Pharmaceutical Industries to market its Malathion Lotion.
- Heard on the Street: Suven Life Sciences climbs on Patent acquisitionsShares of Suven Life Sciences gained around 5% after the company secured four overseas product patents.
- Suven gets patent grants for 2 products in Mexico, KoreaSuven Life Sciences has received patent grants for their two products in Mexico and Korea.
Load More
